All Stories

  1. Preschool wheeze and asthma endotypes- implications for future therapy
  2. European Respiratory Society Research Seminar on Preventing Pediatric Asthma
  3. Association of urinary eosinophilic protein X at age 3 years and subsequent persistence of wheezing and asthma diagnosis in adolescence
  4. Social inequalities in childhood asthma
  5. Featured Cover
  6. Tracing the path from preschool wheezing to asthma
  7. Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction‐Related Biomarkers in Food Protein‐Induced Enterocolitis Syndrome
  8. Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi‐country cross‐sectional survey
  9. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO
  10. Recommendations for asthma monitoring in children.
  11. Component‐specific clusters for diagnosis and prediction of allergic airway diseases
  12. Association between polymorphisms on chromosome 17q12-q21 and rhinovirus-induced interferon responses
  13. Evaluation of measurement errors in the Patient‐Oriented Eczema Measure (POEM) outcome
  14. Component‐resolved diagnosis in childhood and prediction of asthma in early adolescence: A birth cohort study
  15. Understanding progression from pre‐school wheezing to school‐age asthma: Can modern data approaches help?
  16. Phenotype and endotype based treatment of preschool wheeze
  17. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
  18. Reply to Beck et al. and to Owora
  19. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis
  20. Evolution of Lung Function within Individuals: Clinical Insights and Data-driven Methods
  21. EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics
  22. Environmental influences on childhood asthma: Allergens
  23. Will Oral Food Challenges Still Be Part of Allergy Care in 10 Years’ Time?
  24. Early childhood wheezing phenotypes and determinants in a South African birth cohort: longitudinal analysis of the Drakenstein Child Health Study
  25. Dog ownership in infancy is protective for persistent wheeze in 17q21 asthma-risk carriers
  26. Integrative transcriptomic analysis in human and mouse model of anaphylaxis identifies gene signatures associated with cell movement, migration and neuroinflammatory signalling
  27. Progenitor cell‐derived basophils: A novel barcoded passive degranulation assay in allergic diseases
  28. Evolution of Eczema, Wheeze, and Rhinitis from Infancy to Early Adulthood: Four Birth Cohort Studies
  29. A systems immunology approach to investigate cytokine responses to viruses and bacteria and their association with disease
  30. Childhood Asthma Incidence, Early and Persistent Wheeze, and Neighborhood Socioeconomic Factors in the ECHO/CREW Consortium
  31. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
  32. In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection
  33. Defining the normal range of fractional exhaled nitric oxide in children: one size does not fit all
  34. Data‐driven research on eczema: Systematic characterization of the field and recommendations for the future
  35. Update in Asthma 2021
  36. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
  37. Modeling Wheezing Spells Identifies Phenotypes with Different Outcomes and Genetic Associates
  38. Nonlinear effects of environment on childhood asthma susceptibility
  39. Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis
  40. Life-threatening anaphylaxis to peanut — impossible to predict?
  41. Early life inter-kingdom interactions shape the immunological environment of the airways
  42. The Air We Breathe: Respiratory Impact of Indoor Air Quality in Chronic Obstructive Pulmonary Disease
  43. Early‐life predictors and risk factors of peanut allergy, and its association with asthma in later‐life: Population‐based birth cohort study
  44. Considering biomarkers in asthma disease severity
  45. Data-driven research on eczema: systematic characterization of the field and recommendations for the future
  46. Integration of Genomic Risk Scores to Improve the Prediction of Childhood Asthma Diagnosis
  47. The role of growth and nutrition in the early origins of spirometric restriction in adult life: a longitudinal, multicohort, population-based study
  48. Sex differences in innate anti-viral immune responses to respiratory viruses and in their clinical outcomes in a birth cohort study
  49. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
  50. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
  51. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
  52. Modelling trajectories of parentally reported and physician‐confirmed atopic dermatitis in a birth cohort study*
  53. Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4
  54. Development of childhood asthma prediction models using machine learning approaches
  55. Spirometric phenotypes from early childhood to young adulthood: a Chronic Airway Disease Early Stratification study
  56. The change in exhaled nitric oxide in adolescents – a longitudinal cohort study
  57. Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes
  58. Four subtypes of childhood allergic rhinitis identified by latent class analysis
  59. Biomarkers of the Severity of Honeybee Sting Reactions and the Severity and Threshold of Systemic Adverse Events During Immunotherapy
  60. Atopic dermatitis or eczema? Consequences of ambiguity in disease name for biomedical literature mining
  61. Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
  62. Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development
  63. Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort
  64. Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development
  65. Development of Childhood Asthma Prediction Models using Machine Learning Approaches
  66. Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort
  67. Machine learning in asthma research: moving toward a more integrated approach
  68. Four subtypes of childhood allergic rhinitis identified by latent class analysis
  69. Acetate Triggers Antiviral Response Mediated by RIG-I in Cells from Infants with Respiratory Syncytial Virus Bronchiolitis
  70. The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
  71. Genetics of Asthma and Allergic Diseases
  72. Does death from Covid-19 arise from a multi-step process?
  73. The role of interferons in preschool wheeze
  74. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
  75. Circulating Chemokine Levels and the Development of Allergic Phenotypes from Infancy to Adolescence: A Population-Based Birth Cohort Study
  76. Asthma and Allergies: From Diagnosis-Based Approach towards Personalised Treatments
  77. Childhood Asthma: Low and Middle-Income Countries Perspective
  78. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
  79. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?
  80. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
  81. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
  82. Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits
  83. Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthma
  84. Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement
  85. Sex differences in innate anti-viral immune responses to respiratory viruses
  86. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
  87. “Asthma” or “Asthma Spectrum Disorder”?
  88. Atopic phenotypes and their implication in the atopic march
  89. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
  90. Targeting maternal immune function during pregnancy for asthma prevention in offspring: Harnessing the “farm effect”?
  91. Update in Asthma 2019
  92. Update on House Dust Mite Allergen Avoidance Measures for Asthma
  93. Is death from Covid-19 a multistep process?
  94. Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
  95. Toward personalization of asthma treatment according to trigger factors
  96. Is diet partly responsible for differences in COVID-19 death rates between and within countries?
  97. Expression quantitative trait locus fine mapping of the 17q12–21 asthma locus in African American children: a genetic association and gene expression study
  98. Association of bacterial load in drinking water and allergic diseases in childhood
  99. national initiative in data science for health: an evaluation of the UK Farr Institute
  100. Comparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media
  101. Early-life inhalant allergen exposure, filaggrin genotype, and the development of sensitization from infancy to adolescence
  102. Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis
  103. Allergic Endotypes and Phenotypes of Asthma
  104. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air ® App
  105. Longitudinal trajectories of severe wheeze exacerbations from infancy to school age and their association with early‐life risk factors and late asthma outcomes
  106. Comparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media
  107. Differential associations of allergic disease genetic variants with developmental profiles of eczema, wheeze and rhinitis
  108. Toward clinically applicable biomarkers for asthma: An EAACI position paper
  109. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
  110. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
  111. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
  112. Dust-mite inducing asthma: what advice can be given to patients?
  113. Temporal association of the development of oropharyngeal microbiota with early life wheeze in a population-based birth cohort
  114. Distinguishing Wheezing Phenotypes from Infancy to Adolescence. A Pooled Analysis of Five Birth Cohorts
  115. Does understanding endotypes translate to better asthma management options for all?
  116. Blood Biomarkers of Sensitization and Asthma
  117. Epidemiology of Asthma in Children and Adults
  118. A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity
  119. Asthma: moving toward a global children's charter
  120. Nocturnal asthma is affected by genetic interactions between RORA and NPSR1
  121. The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects
  122. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study
  123. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
  124. Different definitions of atopic dermatitis: Impact on prevalence estimates and associated risk factors
  125. The Syndrome We Agreed to Call Bronchiolitis
  126. Childhood Asthma: Advances Using Machine Learning and Mechanistic Studies
  127. Validation of childhood asthma predictive tools: A systematic review
  128. Individual risk assessment tool for school-age asthma prediction in UK birth cohort
  129. Pubertal height growth and lung function in adolescence and early adulthood
  130. Causes of variability in latent phenotypes of childhood wheeze
  131. Pediatric asthma: An unmet need for more effective, focused treatments
  132. Machine learning to identify pairwise interactions between specific IgE antibodies and their association with asthma: A cross-sectional analysis within a population-based birth cohort
  133. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
  134. Trajectories of childhood immune development and respiratory health relevant to asthma and allergy
  135. Evolution of IgE responses to multiple allergen components throughout childhood
  136. Classification of Pediatric Asthma: From Phenotype Discovery to Clinical Practice
  137. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
  138. Reply
  139. Vitamin D receptor genotype influences risk of upper respiratory infection
  140. Author Correction: Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis
  141. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
  142. Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis
  143. Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studies
  144. Pulmonary epithelial barrier and immunological functions at birth and in early life - key determinants of the development of asthma?  A description of the protocol for the Breathing Together study
  145. Cytokine Responses to Rhinovirus and Development of Asthma, Allergic Sensitization, and Respiratory Infections during Childhood
  146. Development of allergic sensitization and its relevance to paediatric asthma
  147. Important and specific role for basophils in acute allergic reactions
  148. Temperature-controlled laminar airflow (TLA) device in the treatment of children with severe atopic eczema: Open-label, proof-of-concept study
  149. Epistasis between FLG and IL4R Genes on the Risk of Allergic Sensitization: Results from Two Population-Based Birth Cohort Studies
  150. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
  151. Cat ownership, cat allergen exposure, and trajectories of sensitization and asthma throughout childhood
  152. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy
  153. Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force
  154. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study
  155. After asthma: redefining airways diseases
  156. Genome-wide search identifies new genetic variants associated with asthma risk.
  157. Non-parametric mixture models identify trajectories of childhood immune development relevant to asthma and allergy
  158. Predictive Modelling Strategies to Understand Heterogeneous Manifestations of Asthma in Early Life
  159. Detection of IgE Reactivity to a Handful of Allergen Molecules in Early Childhood Predicts Respiratory Allergy in Adolescence
  160. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report
  161. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control
  162. Diagnosis of asthma in symptomatic children based on measures of lung function: an analysis of data from a population-based birth cohort study
  163. NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma—implications for home environmental intervention in asthma prevention and management
  164. Features of asthma which provide meaningful insights for understanding the disease heterogeneity
  165. Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis
  166. Shared genetic variants suggest common pathways in allergy and autoimmune diseases
  167. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)
  168. Epigenome-wide analysis links SMAD3 methylation at birth to asthma in children of asthmatic mothers
  169. Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers
  170. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement
  171. Formula one: best is no formula
  172. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
  173. Disaggregating asthma: Big investigation versus big data
  174. Epidemiology of Allergic Diseases
  175. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem
  176. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
  177. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies
  178. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA
  179. Allergy in severe asthma
  180. Asthma phenotypes in childhood
  181. The importance of being earnest in epidemiology
  182. Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA
  183. A new framework for the interpretation of IgE sensitization tests
  184. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
  185. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
  186. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation
  187. Treatment of asthma in young children: evidence-based recommendations
  188. Insoluble and soluble roasted walnut proteins retain antibody reactivity
  189. Age, sex and the association between skin test responses and IgE titres with asthma
  190. Distinguishing benign from pathologic TH2 immunity in atopic children
  191. Evolution pathways of IgE responses to grass and mite allergens throughout childhood
  192. Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index
  193. Relationship between cytokine expression patterns and clinical outcomes: two population‐based birth cohorts
  194. Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years
  195. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis
  196. Atopic Dermatitis and Respiratory Allergy: What is the Link
  197. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
  198. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study
  199. Distinguishing Asthma Phenotypes Using Machine Learning Approaches
  200. The Study Team for Early Life Asthma Research (STELAR) consortium ‘Asthma e-lab’: team science bringing data, methods and investigators together: Figure 1
  201. To what extent is allergen exposure a risk factor for the development of allergic disease?
  202. Developmental Profiles of Eczema, Wheeze, and Rhinitis: Two Population-Based Birth Cohort Studies
  203. A multicentre study of air pollution exposure and childhood asthma prevalence: the ESCAPE project
  204. A novel common variant in DCST2 is associated with length in early life and height in adulthood
  205. Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations
  206. Polymorphisms of endotoxin pathway and endotoxin exposure:in vitroIgE synthesis and replication in a birth cohort
  207. Elemental Composition of Particulate Matter and the Association with Lung Function
  208. Cross-sectional association of dietary patterns with asthma and atopic sensitisation in childhood - in a cohort study
  209. Impact of rhinitis on asthma severity in school-age children
  210. Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: a population-based birth cohort study
  211. Fraction of exhaled nitric oxide values in childhood are associated with 17q11.2-q12 and 17q12-q21 variants
  212. Integrated care pathways for airway diseases (AIRWAYS-ICPs)
  213. Effect of a novel temperature-controlled laminar airflow device on personal breathing zone aeroallergen exposure
  214. Genetic variants in endotoxin signalling pathway, domestic endotoxin exposure and asthma exacerbations
  215. Trajectories of Lung Function during Childhood
  216. Challenges in Interpreting Wheeze Phenotypes: The Clinical Implications of Statistical Learning Techniques
  217. Predicting phenotypes of asthma and eczema with machine learning
  218. Allergen Control for Prevention and Management of Allergic Diseases
  219. Challenges in Identifying Asthma Subgroups Using Unsupervised Statistical Learning Techniques
  220. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations
  221. EAACI position statement on asthma exacerbations and severe asthma
  222. Air Pollution Exposure and Lung Function in Children: The ESCAPE Project
  223. Differing associations of BMI and body fat with asthma and lung function in children
  224. Challenges in interpreting allergen microarrays in relation to clinical symptoms: A machine learning approach
  225. Characterizing wheeze phenotypes to identify endotypes of childhood asthma, and the implications for future management
  226. Long-term Exposure to PM 10 and NO 2 in Association with Lung Volume and Airway Resistance in the MAAS Birth Cohort
  227. Effects of long-term exposure to PM10and NO2on asthma and wheeze in a prospective birth cohort
  228. Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing
  229. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology
  230. Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma
  231. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization
  232. Interaction betweenglutathione S-transferasevariants, maternal smoking and childhood wheezing changes with age
  233. 17q12-21 and asthma: interactions with early-life environmental exposures
  234. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts
  235. Pediatric asthma and development of atopy
  236. Methylation ofIL-2promoter at birth alters the risk of asthma exacerbations during childhood
  237. Asthma severity, polymorphisms in 20p13 and their interaction with tobacco smoke exposure
  238. Pooling Birth Cohorts in Allergy and Asthma: European Union-Funded Initiatives – A MeDALL, CHICOS, ENRIECO, and GA<sup>2</sup>LEN Joint Paper
  239. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
  240. Food protein–induced enterocolitis syndrome can occur in adults
  241. Does Pet Ownership in Infancy Lead to Asthma or Allergy at School Age? Pooled Analysis of Individual Participant Data from 11 European Birth Cohorts
  242. International consensus on (ICON) pediatric asthma
  243. Infantile and preschool asthma
  244. 17q12-21 Variants are associated with asthma and interact with active smoking in an adult population from the United Kingdom
  245. Gene–environment interactions in the development of asthma and atopy
  246. Genetic Variation in Vascular Endothelial Growth Factor-A and Lung Function
  247. Lung development and the role of asthma and allergy
  248. Estimated portion sizes in a school-aged population
  249. Erratum
  250. Davos Declaration: Allergy as a global problem
  251. Research needs in allergy: an EAACI position paper, in collaboration with EFA
  252. Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper
  253. The CREATE Project: Development of Certified Reference Materials for Allergenic Products and Validation of Methods for Their Quantification
  254. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis
  255. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years
  256. Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis
  257. Differences in both prevalence and titre of specific immunoglobulin E among children with asthma in affluent and poor communities within a large town in Ghana
  258. Allergen-specific IgG antibody levels modify the relationship between allergen-specific IgE and wheezing in childhood
  259. Molecular diagnosis of peanut and legume allergy
  260. Peanut allergy: Overestimated in epidemiology or underdiagnosed in primary care?
  261. Quantification of specific IgE to whole peanut extract and peanut components in prediction of peanut allergy
  262. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
  263. Effect of day care attendance on sensitization and atopic wheezing differs by Toll-like receptor 2 genotype in 2 population-based birth cohort studies
  264. Response
  265. Quantification of atopy, lung function and airway hypersensitivity in adults
  266. Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper
  267. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
  268. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma
  269. Allergy is an important factor in asthma exacerbation: A Pro/Con Debate
  270. Increased serum-soluble interleukin-5 receptor alpha level precedes the development of eczema in children
  271. Body mass index in young children and allergic disease: gender differences in a longitudinal study
  272. Beyond Atopy
  273. Changes in the FEV1/FVC ratio during childhood and adolescence: an intercontinental study
  274. Reference equations for specific airway resistance in children: the Asthma UK initiative
  275. Allergy or tolerance in children sensitized to peanut: Prevalence and differentiation using component-resolved diagnostics
  276. Dietary antioxidant intake, allergic sensitization and allergic diseases in young children
  277. Unmet needs in severe chronic upper airway disease (SCUAD)
  278. Prevention of allergic sensitization by environmental control
  279. Spirometry Centile Charts for Young Caucasian Children: The Asthma UK Collaborative Initiative
  280. Allergen Avoidance
  281. Long-Term Effects of Allergen Sensitization and Exposure in Adult Asthma
  282. Immune System Modeling with Infer.NET
  283. The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines
  284. Day-care attendance, position in sibship, and early childhood wheezing: A population-based birth cohort study
  285. Early identification of atopy in the prediction of persistent asthma in children
  286. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper
  287. Gene-Environment Interaction in the Onset of Eczema in Infancy: Filaggrin Loss-of-Function Mutations Enhanced by Neonatal Cat Exposure
  288. Dimensions of Respiratory Symptoms in Preschool Children
  289. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
  290. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
  291. EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification
  292. Bifidobacterium pseudocatenulatum is associated with atopic eczema: A nested case-control study investigating the fecal microbiota of infants
  293. Management of the asthmatic patient
  294. Quantification of atopy and the probability of rhinitis in preschool children: a population-based birth cohort study
  295. Two blind mice: New insights into mouse allergy
  296. Staphylococcus aureus sensitization and allergic disease in early childhood: Population-based birth cohort study
  297. Original article: Rhinoconjunctivitis in 5-year-old children: a population-based birth cohort study
  298. Active smoking among asthmatic youth?How concerned we need to be
  299. Exercise-Induced Bronchospasm and Atopy in Ghana: Two Surveys Ten Years Apart
  300. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)
  301. European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures – a GA2LEN initiative
  302. Endotoxin Exposure, CD14, and Allergic Disease
  303. Exhaled Breath Condensate pH and Childhood Asthma
  304. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study
  305. Allergen avoidance in the secondary and tertiary prevention of allergic diseases: does it work?
  306. Atopic wheezing and early life antibiotic exposure: a nested case-control study
  307. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children
  308. Dietary intake in sensitized children with recurrent wheeze and healthy controls: a nested case-control study
  309. Environmental exposures, genetic predisposition and allergic diseases: one size never fits all
  310. Intranasal air sampling in homes: Relationships among reservoir allergen concentrations and asthma severity
  311. Domestic allergen and endotoxin exposure and allergic sensitization in Cyprus
  312. Drugs used in paediatric allergy: should we conduct studies in children or extrapolate from adults?
  313. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs - a GA2LEN initiative
  314. Epidemiology of Allergic Disease
  315. Fungal contamination of bedding
  316. High-efficiency vacuum cleaners increase personal mite allergen exposure, but only slightly
  317. What are we learning from genetic cohort studies?
  318. Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization
  319. IgE antibody quantification and the probability of wheeze in preschool children
  320. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA2LEN)
  321. Polymorphisms in A Disintegrin and Metalloprotease 33 ( ADAM33 ) Predict Impaired Early-Life Lung Function
  322. The information needs and preferred roles in treatment decision-making of parents caring for infants with atopic dermatitis: a qualitative study
  323. The role of allergen avoidance in the secondary prevention of atopic disorders
  324. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study
  325. Pets and the development of allergic sensitization
  326. Potential roles in rhinitis for protease and other enzymatic activities of allergens
  327. Allergy and infection: understanding their relationship
  328. Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis
  329. Behavior Problems Antecede the Development of Wheeze in Childhood
  330. Wheeze Phenotypes and Lung Function in Preschool Children
  331. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects
  332. Asthma and sensitization in a community with low indoor allergen levels and low pet-keeping frequency
  333. Environmental allergen exposure, sensitisation and asthma: from whole populations to individuals at risk
  334. Lung Function at Age 3 Years
  335. World Allergy Organization Guidelines for Prevention of Allergy and Allergic Asthma
  336. Early Life Environmental Control
  337. Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects
  338. Response to ‘No clinical evidence base to support the hygiene hypothesis’ by C. P. van Schayck and J. A. Knottnerus
  339. No clinical evidence base to support the hygiene hypothesis
  340. Protective parasites and medicinal microbes? The case for the hygiene hypothesis
  341. Reported versus confirmed wheeze and lung function in early life
  342. Allergens, Viruses, and Asthma Exacerbations
  343. Childhood asthma
  344. Allergen avoidance in the primary prevention of asthma
  345. Can we prevent allergy?
  346. World Allergy Organization Guidelines for Prevention of Allergy and Allergic Asthma
  347. Manchester cohort
  348. The role of allergen avoidance in primary and secondary prevention
  349. Tobacco smoke exposure, wheeze, and atopy
  350. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients
  351. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3 years of age
  352. Primary and secondary prevention of allergic airway disease
  353. Stringent environmental control in pregnancy and early life: the long-term effects on mite, cat and dog allergen
  354. Childhood asthma, behavior problems, and family functioning
  355. Endotoxin contamination contributes to the pulmonary inflammatory and functional response to Aspergillus fumigatus extract inhalation in heaves horses
  356. Exposure and sensitization to indoor allergens: Association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma
  357. Control of Exposure to Mite Allergen and Allergen-Impermeable Bed Covers for Adults with Asthma
  358. Air filtration units in homes with cats: can they reduce personal exposure to cat allergen?
  359. High-efficiency particulate arrest–filter vacuum cleaners increase personal cat allergen exposure in homes with cats
  360. Childhood asthma
  361. Current mite, cat, and dog allergen exposure, pet ownership, and sensitization to inhalant allergens in adults
  362. Early pet exposure: friend or foe?
  363. Clinical effects of air filters in homes of asthmatic adults sensitized and exposed to pet allergens
  364. Skin test reactivity to natural and recombinant Blomia and Dermatophagoides spp. allergens among mite allergic patients in the UK
  365. The National Asthma Campaign Manchester Asthma and Allergy Study
  366. Clostridium difficile , atopy and wheeze during the first year of life
  367. Household characteristics and mite allergen levels in Manchester,UK
  368. The effect of allergen exposure in early childhood on the development of atopy
  369. Preventive measures and their effects
  370. Seasonal variability in exercise test responses in Ghana
  371. Specific airway resistance in 3-year-old children: a prospective cohort study
  372. Personal exposure to house dust mite allergen in bed: nasal air sampling and reservoir allergen levels
  373. Controlling indoor allergens
  374. Is allergen avoidance effective?*
  375. Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population
  376. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study
  377. Array-based diagnostic gene-expression score for atopy and asthma
  378. Environmental allergens in Kuwait
  379. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study
  380. Decreased prevalence of sensitization to cats with high exposure to cat allergen
  381. The role of indoor allergen exposure in the development of sensitization and asthma
  382. The role of indoor allergen exposure in the development of sensitization and asthma
  383. Pet allergen levels in homes in Ghana and the United Kingdom
  384. Risk factors for asthma in urban Ghana
  385. Avoidance of allergens and air pollutants in respiratory allergy
  386. Lymphoproliferative responses in cord blood and at one year: no evidence for the effect of in utero exposure to dust mite allergens
  387. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial
  388. Housing characteristics and mite allergen levels: to humidity and beyond
  389. On allergens and asthma (again): does exposure to allergens in homes exacerbate asthma?
  390. Exposure and sensitization in infants and children
  391. Exposure and sensitization in infants and children
  392. NAC Manchester Asthma and Allergy Study (NAC MAAS): risk factors for asthma and allergic disorders in adults
  393. Apoptosis signals in atopy and asthma measured with cDNA arrays
  394. Environmental allergen exposure and asthma: prospects for primary prevention
  395. The −403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma
  396. Chapter 1: Genetic and Environmental Influences
  397. Prevention of Allergy and Asthma
Interim Report
  398. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study
  399. Synthetic pillows contain higher levels of cat and dog allergen than feather pillows
  400. Manchester Asthma and Allergy Study: Low-allergen environment can be achieved and maintained during pregnancy and in early life
  401. Clinical Effects of Allergen Avoidance
  402. Allergen avoidance: does it work?
  403. Dust mite allergens are carried on not only large particles
  404. Exhaled Nitric Oxide, Sensitization, and Exposure to Allergens in Patients with Asthma Who Are Not Taking Inhaled Steroids
  405. Relationship between mite, cat, and dog allergens in reservoir dust and ambient air
  406. Attempting to control mite allergens with mechanical ventilation and dehumidification in British houses
  407. The effect of air filtration on airborne dog allergen
  408. Mite allergens in feather and synthetic pillows
  409. Vacuum cleaners and airborne dog allergen
  410. Washing the dog reduces dog allergen levels, but the dog needs to be washed twice a week
  411. Sensitivity and exposure to indoor allergens in adults with differing asthma severity
  412. Feather or synthetic? That is the question
  413. The effect of dry heat on mite, cat, and dog allergens
  414. Importance of indoor allergens in the induction of allergy and elicitation of
  415. Risk levels for mite allergens. Are they meaningful?
  416. Indoor environmental factors and respiratory illness
  417. Role of the indoor environment in determining the severity of asthma
  418. Variability of house-dust-mite allergen levels within carpets
  419. ABC of allergies: Avoiding exposure to indoor allergens
  420. Allergen avoidance in the treatment of asthma and atopic disorders
  421. Distribution, aerodynamic characteristics, and removal of the major cat allergen Fel d 1 in British homes
  422. Domestic allergens in public places III: house dust mite, cat, dog and cockroach allergens in British hospitals
  423. Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren
  424. Aerodynamic properties of the major dog allergen Can f 1: distribution in homes, concentration, and particle size of allergen in the air.
  425. Domestic allergens in public places II: dog (Can f 1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in the air in public buildings
  426. New mattresses: how fast do they become a significant source of exposure to house dust mite allergens?
  427. Domestic allergens in public places II: dog (Can f 1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in the air in public buildings
  428. New mattresses: how fast do they become a significant source of exposure to house dust mite allergens?
  429. Reduction in humidity as a method of controlling mites and mite allergens: the use of mechanical ventilation in British domestic dwellings
  430. Reduction in humidity as a method of controlling mites and mite allergens: the use of mechanical ventilation in British domestic dwellings
  431. Exposure to house dust mite allergens and the clinical activity of asthma
  432. Asthmatic bronchial hyperresponsiveness varies with ambient levels of summertime air pollution
  433. Evaluating exposure to mite allergens
  434. GR106642X: a new, non-ozone depleting propellant for inhalers
  435. Portable dehumidifiers in the control of house dust mites and mite allergens
  436. House dust mite and cat allergen in different indoor environments
  437. Assessing Exercise-induced Bronchospasm
  438. Exercise Testing Revisited
  439. Animal Allergens
  440. Does Allergen Avoidance Help? What are the Practical Measures that Patients can Take?